EBV encephalitis
Basic details
Preferred term: EBV encephalitis
Alt. terms: Epstein-Barr virus encephalitis | herpesvirus 4 encephalitis
HPO term: EBV encephalitis
HPO code: HP:0033509
GenIA ID: 13769
Last updated on: 2024-05-02 19:39:32
Cross ref. with other ontologies
NCIT: -
MESH: -
EFO: -
OAE: -
SNOMEDCT: -
ICD10: -
Description
Inflamation of the brain related to infection by Epstein-Barr virus.
Hierarchical classification
TERM
EBV encephalitis
CHILD terms
Reported patients added to GenIA DB
| SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
|---|---|---|---|---|---|---|---|
| 101015 | M | 210203 | - | German | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [MM.II.1]; PMID:29729943 [Fam.MM:II.1(87)]; PMID:34975878 [Fam.F002:P002]; PMID:31857261 [Patient 3]; PMID:34111452 [AM.II.1 (87)] |
| 101037 | M | 210182 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.4(B.II.3)]; PMID:30250467 [B.II.3]; PMID:29729943 [Fam.B:II.4(B.II.3 (15))]; PMID:27418640 [P13(5)]; PMID:34111452 [B.II.3 (15)] |
| 101038 | F | 210182 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.6(B.II.4)]; PMID:30250467 [B.II.4]; PMID:29729943 [Fam.B:II.6(B.II.4 (16))]; PMID:34975878 [Fam.F014:III.6(P015)]; PMID:27418640 [P14(5)]; PMID:34111452 [B.II.4 (16)] |
| 101040 | F | 210724 |
20 | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.GG:II.1(GG.II.1 (79))]; PMID:31857261 [Patient 15]; PMID:34111452 [AG.II.1 (79)] |
| 101043 | M | 210725 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.H:II.2(H.II.2 (30))]; PMID:34975878 [Fam.F017:P017]; PMID:34111452 [H.II.2 (30)] |
| 101089 | M | 211033 | - | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F055:P055] | ||
| 101091 | M | 210911 | - | (unusual) Epstein-Barr virus infection | DiGeorge syndrome | PMID:34975878 [Fam.F057:P057]; PMID:35486341 [P180] | |
| 101132 | M | 210304 | 19 | German | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F081:P081] | |
| 101133 | M | 210896 | 19 | (unusual) Epstein-Barr virus infection | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
| 101155 | M | 210235 | - | German | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [JJ.II.I]; PMID:29729943 [Fam.JJ:II.1(83)]; PMID:34975878 [Fam.F098:P098]; PMID:34111452 [AJ.II.1 (83)] |
| 101204 | M | 211492 | 45 | German | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F126:P126] | |
| 101461 | M | 210929 | - | German | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F153:P153]; PMID:32278790 [Z.I.1]; PMID:29403474 [Patient 27 (11)]; PMID:27923702 [Patient 6]; PMID:150198 [Fam.AL:151]; PMID:27461466 [Fam.830_01:27] |
| 101473 | F | 212398 | 1 | Spanish | (unusual) Epstein-Barr virus infection | Immunodeficiency, common variable, 8 | PMID:30386343 [Patient(II.1)] |
| 101479 | F | 210314 |
- | German | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F160:P160]; PMID:32278790 [Fam.BF:II.2(II.2)]; PMID:29403474 [Fam.(13):II.1(Patient 2)]; PMID:27923702 [Fam.191:II.1(Patient 2)]; PMID:150198 [Fam.AO:II.2(164)]; GRID:001142 [Fam.#:II.2(FR036)] |
| 101529 | M | 211278 | 20 | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F176:P176] | ||
| 101651 | M | 210939 | - | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F226:P226] | ||
| 101797 | M | 211108 | - | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.QQ:II.1(97)]; PMID:34975878 [Fam.F258:P258]; PMID:34111452 [AQ.II.1 (97)] |
| 101947 | M | 211945 | 29 | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F348:P348] | ||
| 101957 | M | 212517 | 25 | (unusual) Epstein-Barr virus infection | PMID:34975878 [Fam.F391:P391] | ||
| 102175 | M | 210725 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [H.II.1]; PMID:29729943 [Fam.H:II.1(H.II.1 (29))]; PMID:34111452 [H.II.1 (29)] |
| 102225 | M | 214920 | - | Romanian | (unusual) Epstein-Barr virus infection | Immunodeficiency 40 | PMID:35486341 [P063] |
| 102226 | F | 214921 | - | Russian | (unusual) Epstein-Barr virus infection | Activated p110-d syndrome 2 | PMID:35486341 [P094] |
| 102865 | F | 214996 |
3 | Italian | (unusual) Epstein-Barr virus infection | ARPC1B deficiency | Hartnup disease | PMID:35967303 [PtII-1(II.1)]; PMID:35967303 [PtII-1(II.1)] |
| 102934 | F | 215035 |
- | Caucasian | (unusual) Epstein-Barr virus infection | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P23]; PMID:33464451 [P14(III.1)]; PMID:37419334 [P23(22)] |
| 103076 | F | 215099 |
3 | Omani | (unusual) Epstein-Barr virus infection | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F5:V.5(P6)] |
| 103542 | M | 215156 |
- | Mexican | (unusual) Epstein-Barr virus infection | ARPC1B deficiency | PMID:36708766 [Fam.C:II.3(P5)] |
| 104453 | F | 215530 |
- | European | (unusual) Epstein-Barr virus infection | Early-onset atopic inflammation | PMID:36884218 [Fam.D:II.1(P5)] |
| 105057 | F | 215635 |
- | German | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:32278790 [S.I.1]; PMID:29403474 [Patient 1 (8)]; PMID:27365489 [Fam.1:II.1(Pat.1)]; PMID:150198 [Fam.AE:II.1(121)] |
| 105105 | F | 215643 |
18 | Caucasian | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.AB:II.1(II.1)]; PMID:29403474 [Fam.(7):II.1(Index)]; PMID:27338827 [Fam.1:II.1(II-1)]; PMID:150198 [Fam.AD:II.1(117)] |
| 105180 | M | 215662 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.S:II.1(47)]; PMID:27102614 [Fam.D:II.1(P5)]; PMID:34111452 [S.II.1 (47)] |
| 105333 | F | 215695 | - | European | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:32278790 [N.II.1]; PMID:29477724 [Fam.N:II.1(II:1)]; PMID:150198 [Fam.BH:286] |
| 105378 | F | 215729 | - | (unusual) Epstein-Barr virus infection | Immunodeficiency 84 | PMID:34155405 [Fam.1:II.3(p1)] | |
| 105379 | M | 215730 | - | (unusual) Epstein-Barr virus infection | Immunodeficiency 84 | PMID:34155405 [Fam.2:III.2(p2)] | |
| 105380 | F | 215731 | - | (unusual) Epstein-Barr virus infection | Immunodeficiency 84 | PMID:34155405 [Fam.2:III.1(p3)] | |
| 105732 | M | 215844 | - | (unusual) Epstein-Barr virus infection | Immunodeficiency, X-linked, with magnesium defect, EBV infection and neoplasia | PMID:21796205 [Fam.A:IV.1(1)] | |
| 105910 | F | 215905 | - | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(33)]; PMID:34111452 [K.II.1 (33)] |
| 105926 | M | 215909 |
- | Japanese | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.N:III.2(N.III.2 (41))]; PMID:34111452 [N.III.2 (41)]; PMID:35087518 [Fam.12:III.2(12.4)] |
| 105968 | M | 215916 |
- | Japanese | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.U:II.1(U.II.1 (50))]; PMID:30048690 [Fam.1:II.1(P1.2)]; PMID:34111452 [U.II.1 (50)]; PMID:35087518 [Fam.13:II.1(13.2)]; PMID:28960754 [CTLA4-Case1] |
| 105974 | M | 215918 |
- | Japanese | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.W:I.1(W.I.1 (54))]; PMID:30048690 [Fam.2:I.1(P2.1)]; PMID:34111452 [W.I.1 (54)]; PMID:35087518 [Fam.15:I.1(15.1)] |
| 105977 | F | 215918 |
- | Japanese | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.W:II.2(W.II.2 (56))]; PMID:30048690 [Fam.2:II.2(P2.2)]; PMID:34111452 [W.II.2 (56)]; PMID:35087518 [Fam.15:II.2(15.3)] |
| 106047 | F | 215930 | - | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.LL:II.1(LL.II.1 (86))]; PMID:34111452 [AL.II.1 (86)] |
| 106057 | F | 210991 |
- | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.8(NN.II.6 (90))]; PMID:34111452 [AN.II.6 (90)] |
| 106068 | M | 215931 | - | Caucasian | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.PP:II.1(96)]; PMID:34111452 [AP.II.1 (96)] |
| 106090 | M | 215946 |
- | Saudi | (unusual) Epstein-Barr virus infection | T-cell immunodeficiency with thymic aplasia | PMID:33464451 [P11]; PMID:37419334 [P11(27)]; PMID:31151968 [Fam.1:II.2(Patient)] |
| 106145 | M | 215954 | - | Slovak | (unusual) Epstein-Barr virus infection | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:33464451 [P9]; PMID:37419334 [P9(27)] |
| 106697 | F | 216110 | - | Japanese | (unusual) Epstein-Barr virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30048690 [Fam.7:7.1]; PMID:35087518 [Fam.20:20.1] |
| 106939 | M | 216189 |
49 | Caucasian | (unusual) Epstein-Barr virus infection | NFKB1 insufficiency | PMID:150198 [Fam.FW:II.1(772)]; PMID:38423196 [Fam.1:II.1(P1)] |
| 107259 | M | 216403 | 28 | North American | (unusual) Epstein-Barr virus infection | Hemophagocytic lymphohistiocytosis, familial 5 | PMID:27379089 [P15] |
| 107296 | M | 216422 |
- | Palestinian | (unusual) Epstein-Barr virus infection | Hemophagocytic lymphohistiocytosis, familial 5 | PMID:19884660 [Fam.4:II.1(F4P1)] |
| 107381 | M | 216458 | 1 | Chinese (China) | (unusual) Epstein-Barr virus infection | Leukocyte adhesion deficiency, type I | PMID:31374327 [Patient(I.2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).